Roche Revenue Lifted by Cancer and Immunology Drugs
Roche Holding reported an increase in first-quarter revenue following strong sales of its cancer and immunology drugs.
Roche Holding reported an increase in first-quarter revenue following strong sales of its cancer and immunology drugs.